洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2000040121】The Status of Hope in Chinese Patients on Peritoneal Dialysis

基本信息
登记号

ChiCTR2000040121

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2020-11-21

临床申请受理号

/

靶点

/

适应症

End-stage renal disease

试验通俗题目

The Status of Hope in Chinese Patients on Peritoneal Dialysis

试验专业题目

The Status of Hope in Chinese Patients on Peritoneal Dialysis: A Mixed Methods Study

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

联系人通讯地址
临床试验信息
试验目的

This exploratory mixed-methods study aims to develop a model to understand the level, concept, development, and impact of hope in Chinese renal patients on PD. The four research questions that will guide this study are: 1. What is the level of hope perceived by Chinese renal patients on PD? 2. Does the level of hope affect HRQoL, anxiety, and depression in these patients? 3. What does hope mean to these patients? 4. What can be helpful to foster hope from patients perspectives?

试验分类
试验类型

连续入组

试验分期

其它

随机化

No

盲法

N/A

试验项目经费来源

Nethersole Institute of Continuing Holistic Health Education

试验范围

/

目标入组人数

134

实际入组人数

/

第一例入组时间

2021-04-01

试验终止时间

2022-07-03

是否属于一致性

/

入选标准

Eligible participants should meet the following criteria: 1) Chinese >=18 years old; 2) diagnosed with ESRD (glomerular filtration rate <=15 ml/min/1.73m2 as estimated by CKD-EPI equation); 3) received automated PD or continuous ambulatory PD for at least three consecutive months; 4) able to communicate in Cantonese; 5) able to give informed consent.;

排除标准

1) cannot communicate in Cantonese; 2) refuse to provide written consent; 3) have active mental health disorders (e.g., schizophrenia) will be excluded from this study.;

研究者信息
研究负责人姓名
试验机构

香港中文大學醫學院那打素護理學院

研究负责人电话
研究负责人邮箱
研究负责人邮编

/

联系人通讯地址
<END>

香港中文大學的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品